Company / SG&A per Share
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.47
FY2025
5-year range
$0.47 / $0.72
FY2021-FY2025
Trend
-22.3%
vs FY2024
Sector context
#149 of 156
Health Care
What the data says
Among 156 Health Care companies, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is in the top 4% for sg&a per share. SG&A per Share has declined for 3 consecutive years, from $0.72 in FY2022 to $0.47 in FY2025.
Based on SEC 10-K filings.
0.47 in FY2025 with a 5-year CAGR of +2.5%.
Improved from $0.67 to $0.47 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -13.0%
- 5-Year CAGR
- +2.5%
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 156This company $0.47 Sector average $11421.53
▼
-100.0% below sector average
Key checks
Key Insights
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s sg&a per share has declined for 3 consecutive years.
- In FY2025, sg&a per share decreased 22.3% year-over-year.
- Ranks #149 out of 156 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.47 | -22.3% |
| FY2024 | $0.61 | -9.4% |
| FY2023 | $0.67 | -6.5% |
| FY2022 | $0.72 | +17.8% |
| FY2021 | $0.61 | +46.1% |
| FY2020 | $0.42 | -15.9% |
| FY2019 | $0.49 | -9.4% |
| FY2018 | $0.55 | -14.4% |
| FY2017 | $0.64 | +6.8% |
| FY2016 | $0.60 | +14.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026